ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

IKT Inhibikase Therapeutics Inc

1.82
-0.05 (-2.67%)
Apr 25 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Inhibikase Therapeutics Inc IKT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.05 -2.67% 1.82 19:01:54
Open Price Low Price High Price Close Price Prev Close
1.745 1.7119 1.90 1.90 1.87
more quote information »

Recent News

Date Time Source Heading
4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/18/202416:30GLOBEInhibikase Therapeutics Issues Letter to Shareholders and..
4/03/202408:05GLOBEInhibikase Therapeutics Announces Pre-IND Meeting with the..
3/27/202416:15GLOBEInhibikase Therapeutics Reports Fourth Quarter and Full Year..
3/07/202408:30GLOBEInhibikase Therapeutics to Provide Trial Update for..
2/28/202416:05GLOBEInhibikase Therapeutics Announces Full Outcomes of its..
2/07/202407:59EDGAR2Form 8-K - Current report
2/07/202407:55GLOBEInhibikase Therapeutics Announces Preliminary Outcomes of..
2/01/202416:49EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2/01/202416:09EDGAR2Form 8-K - Current report
1/29/202409:05GLOBEInhibikase Therapeutics Announces Publication Highlighting..
1/16/202416:31EDGAR2Form 8-K - Current report
1/16/202416:05GLOBEInhibikase Therapeutics Announces Planned Retirement of..
12/19/202308:30GLOBEInhibikase Therapeutics Issues Letter to Shareholders and..
12/04/202308:35GLOBEInhibikase Therapeutics Granted Pre-NDA Meeting with the FDA..
11/14/202316:30GLOBEInhibikase Therapeutics Reports Third Quarter Financial..
11/07/202309:28GLOBECorrecting & Replacing -- Inhibikase Therapeutics to Report..
11/07/202308:00GLOBEInhibikase Therapeutics to Report Second Quarter Financial..
10/16/202317:24EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
10/16/202307:00GLOBEInhibikase Therapeutics Highlights Unblinded Functional..
10/04/202308:30GLOBEInhibikase Therapeutics Receives FDA Orphan Drug Designation..
9/20/202311:23EDGAR2Form 8-K - Current report
8/24/202308:30PRNUSInhibikase Therapeutics Announces Development of Novel..
8/22/202308:05PRNUSInhibikase Therapeutics to Present at the International..
8/21/202308:30PRNUSInhibikase Therapeutics Initiates Development of Second..
8/17/202308:30PRNUSInhibikase Therapeutics Announces Completion of the 501..
8/14/202316:20PRNUSInhibikase Therapeutics Reports Second Quarter Financial..
8/14/202316:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/202308:05PRNUSInhibikase Therapeutics to Report Second Quarter Financial..
7/17/202317:29EDGAR2Form 8-K - Current report
7/17/202316:05PRNUSInhibikase Therapeutics Regains Compliance with Nasdaq..
7/05/202321:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/05/202321:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/29/202312:15EDGAR2Form 8-K - Current report
6/29/202309:29PRNUSInhibikase Therapeutics Announces a 1-for-6 Reverse Stock..
6/22/202308:05PRNUSInhibikase Therapeutics Announces Selection of the..
6/21/202308:05PRNUSInhibikase Therapeutics Initiates Medical and Patient..
5/30/202308:05PRNUSInhibikase Therapeutics to Present at the LD Micro..
5/16/202307:45PRNUSInhibikase Therapeutics Announces Dosing of First Patient in..
5/15/202308:30PRNUSInhibikase Therapeutics Reports First Quarter Financial..
5/08/202308:05PRNUSInhibikase Therapeutics to Report First Quarter Financial..
5/04/202308:05PRNUSInhibikase Therapeutics to Present at the Sidoti Micro-Cap..

Your Recent History

Delayed Upgrade Clock